A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic salivary gland cancers (R/M SGCs).

出版年份 2021 全文链接

标题

作者

关键词

出版物

Volume 39, Issue 15_suppl, Pages 6002-6002

出版商

American Society of Clinical Oncology (ASCO)

发表日期

2021-06-02

DOI

10.1200/jco.2021.39.15_suppl.6002

Explore over 38,000 international journals covering a vast array of academic fields.

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now